Burlington, KY, United States of America

Thomas C Ryle

This inventor holds 1 USPTO granted patent. Top assignee: Clopay Corporation. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas C. Ryle

Introduction

Thomas C. Ryle is a notable inventor based in Burlington, KY (US). He has made significant contributions to the field of materials science, particularly in the development of nonwoven fibrous embossed plastic films. His innovative work has led to the creation of a unique product that combines functionality with aesthetic appeal.

Latest Patents

Ryle holds a patent for a nonwoven fibrous embossed plastic film. This embossed thermoplastic liquid barrier film features a visible nonwoven fibrous three-dimensionally embossed pattern on both sides. The films have thicknesses ranging from about 0.5 to about 2 mils, with an embossed depth that provides a soft hand feel while maintaining its liquid barrier properties.

Career Highlights

Throughout his career, Thomas C. Ryle has been associated with Clopay Corporation, where he has applied his expertise in materials to develop innovative products. His work has not only advanced the company's product offerings but has also contributed to the broader field of polymer science.

Collaborations

Ryle has collaborated with talented individuals such as Leopoldo V. Cancio and Pai-Chuan Wu. These partnerships have fostered a creative environment that encourages innovation and the development of new technologies.

Conclusion

Thomas C. Ryle's contributions to the field of materials science, particularly through his patented nonwoven fibrous embossed plastic film, highlight his role as an influential inventor. His work continues to impact the industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…